抗缪勒管激素在包括多囊卵巢综合征在内的排卵障碍性疾病鉴别诊断中的应用。
Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS.
机构信息
Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy.
Clinica EUGIN, Modena, Italy.
出版信息
Front Endocrinol (Lausanne). 2021 Feb 3;11:616766. doi: 10.3389/fendo.2020.616766. eCollection 2020.
Abstract
Since the historical use of gonadotrophin and estradiol levels to define the different anovulatory disorders has shown some limitations, the use of other markers such as anti-müllerian hormone (AMH) has been proposed. This review addresses the role of AMH in the differential diagnosis of anovulatory disorders, especially focusing on its value in the prognostic characterization of their severity. Current limitations and future clinical applications are discussed.
摘要
由于历史上使用促性腺激素和雌二醇水平来定义不同的排卵障碍存在一些局限性，因此提出了使用其他标志物（如抗缪勒管激素（AMH））的方法。本文探讨了 AMH 在排卵障碍鉴别诊断中的作用，特别是其在预测疾病严重程度方面的价值。讨论了当前的局限性和未来的临床应用。
相似文献
1
Use of AMH in the Differential Diagnosis of Anovulatory Disorders Including PCOS.抗缪勒管激素在包括多囊卵巢综合征在内的排卵障碍性疾病鉴别诊断中的应用。
Front Endocrinol (Lausanne). 2021 Feb 3;11:616766. doi: 10.3389/fendo.2020.616766. eCollection 2020.
2
Polycystic ovary syndrome, amenorrhea and the diagnostic role of anti-Müllerian hormone.多囊卵巢综合征、闭经与抗苗勒管激素的诊断作用。
Minerva Endocrinol. 2020 Dec;45(4):376-380. doi: 10.23736/S0391-1977.20.03390-8.
3
A patient-specific model combining antimüllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders.结合抗苗勒管激素和体重指数的患者特异性模型，用于预测多囊卵巢综合征和其他少排卵障碍。
Fertil Steril. 2021 Jan;115(1):229-237. doi: 10.1016/j.fertnstert.2020.07.023. Epub 2020 Oct 16.
4
The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.抗苗勒管激素在多囊卵巢综合征发病机制及病理生理特征中的作用
Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:82-7. doi: 10.1016/j.ejogrb.2016.01.029. Epub 2016 Feb 10.
5
Revised criteria for PCOS in WHO Group II anovulatory infertility - a revival of hypothalamic amenorrhoea?世界卫生组织II型无排卵性不孕症中多囊卵巢综合征的修订标准——下丘脑性闭经的复苏？
Clin Endocrinol (Oxf). 2015 Apr;82(4):584-91. doi: 10.1111/cen.12621. Epub 2014 Nov 5.
6
The role of anti-Müllerian hormone in the classification of anovulatory infertility.抗苗勒管激素在无排卵性不孕症分类中的作用
Eur J Obstet Gynecol Reprod Biol. 2015 Mar;186:75-9. doi: 10.1016/j.ejogrb.2015.01.007. Epub 2015 Jan 23.
7
Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.瘦女性抗苗勒管激素水平升高可能并不意味着患有多囊卵巢综合征。
Aust N Z J Obstet Gynaecol. 2017 Oct;57(5):552-557. doi: 10.1111/ajo.12647. Epub 2017 Jun 9.
8
[Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].[抗苗勒管激素在多囊卵巢综合征主要表型中的作用]
Akush Ginekol (Sofiia). 2014;53(5):22-7.
9
Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.将血清抗苗勒管激素检测作为多囊卵巢形态的替代指标：对多囊卵巢综合征的诊断和表型分类的影响。
Hum Reprod. 2017 Aug 1;32(8):1716-1722. doi: 10.1093/humrep/dex239.
10
Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.多囊卵巢形态学与多囊卵巢综合征的诊断：应用聚类分析重新定义卵泡计数和血清抗苗勒管激素的临界值。
Hum Reprod. 2017 Aug 1;32(8):1723-1731. doi: 10.1093/humrep/dex226.
引用本文的文献
1
A Genome-Wide Association Study of Anti-Müllerian Hormone (AMH) Levels in Samoan Women.萨摩亚女性抗苗勒管激素（AMH）水平的全基因组关联研究。
Genes (Basel). 2025 Jun 30;16(7):793. doi: 10.3390/genes16070793.
2
Assessing the clinical diagnostic value of anti-Müllerian hormone in polycystic ovarian syndrome and its correlation with clinical and metabolism indicators.评估抗缪勒管激素在多囊卵巢综合征中的临床诊断价值及其与临床和代谢指标的相关性。
J Ovarian Res. 2024 Apr 10;17(1):78. doi: 10.1186/s13048-024-01405-4.
3
Antimüllerian hormone level predicts ovulation in women with polycystic ovary syndrome treated with clomiphene and metformin.抗苗勒氏管激素水平可预测克罗米酚和二甲双胍治疗多囊卵巢综合征妇女的排卵情况。
Fertil Steril. 2024 Apr;121(4):660-668. doi: 10.1016/j.fertnstert.2023.12.031. Epub 2023 Dec 26.
4
Alteration of Plasma Indoles in Polycystic Ovary Syndrome.多囊卵巢综合征患者血浆吲哚的变化
Reprod Sci. 2024 Mar;31(3):764-772. doi: 10.1007/s43032-023-01377-8. Epub 2023 Oct 12.
5
TGFß Gene Members and Their Regulatory Factors in Granulosa Compared to Cumulus Cells in PCOS: A Case-Control Study.多囊卵巢综合征中颗粒细胞与卵丘细胞相比的TGFβ基因成员及其调控因子：一项病例对照研究
Cell J. 2022 Jul 27;24(7):410-416. doi: 10.22074/cellj.2022.8051.
6
Nomogram of age-specific anti-Müllerian hormone levels in healthy Egyptian females.埃及健康女性特定年龄段抗苗勒管激素水平的列线图。
PLoS One. 2021 Jul 26;16(7):e0254858. doi: 10.1371/journal.pone.0254858. eCollection 2021.
本文引用的文献
1
In vitro maturation of oocytes for preserving fertility in autoimmune premature ovarian insufficiency.卵母细胞体外成熟用于自身免疫性卵巢早衰患者的生育力保存。
Fertil Steril. 2020 Oct;114(4):848-853. doi: 10.1016/j.fertnstert.2020.04.049. Epub 2020 Jul 22.
2
Anti-Müllerian Hormone and Ovarian Morphology in Women With Hypothalamic Hypogonadism.抗缪勒管激素与下丘脑性性腺功能减退症女性的卵巢形态。
J Clin Endocrinol Metab. 2020 May 1;105(5). doi: 10.1210/clinem/dgaa116.
3
A gene regulatory network for Müllerian duct regression.一个关于苗勒管退化的基因调控网络。
Environ Epigenet. 2019 Sep 25;5(3):dvz017. doi: 10.1093/eep/dvz017. eCollection 2019 Jul.
4
Clinical application of serum anti-Müllerian hormone in women.血清抗苗勒管激素在女性中的临床应用
Clin Exp Reprod Med. 2019 Jun;46(2):50-59. doi: 10.5653/cerm.2019.46.2.50. Epub 2019 Jun 1.
5
Anti-Müllerian Hormone in PCOS: A Review Informing International Guidelines.多囊卵巢综合征中的抗缪勒管激素：国际指南制定的相关综述。
Trends Endocrinol Metab. 2019 Jul;30(7):467-478. doi: 10.1016/j.tem.2019.04.006. Epub 2019 May 31.
6
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.国际循证指南关于多囊卵巢综合征评估和管理的推荐意见。
Fertil Steril. 2018 Aug;110(3):364-379. doi: 10.1016/j.fertnstert.2018.05.004. Epub 2018 Jul 19.
7
Anti-Müllerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH.孤立性低促性腺激素性性腺功能减退/卡尔曼综合征女性的抗苗勒管激素与卵巢形态：重组人促卵泡生成素的作用
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1102-1111. doi: 10.1210/jc.2016-3799.
8
Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement.三种新型商用抗苗勒管激素检测免疫分析方法的比较评估
Hum Reprod. 2016 Dec;31(12):2796-2802. doi: 10.1093/humrep/dew248. Epub 2016 Oct 4.
9
New automated antimüllerian hormone assays are more reliable than the manual assay in patients with reduced antral follicle count.新的自动化抗缪勒管激素检测比手动检测在窦卵泡计数减少的患者中更可靠。
Fertil Steril. 2016 Dec;106(7):1800-1806. doi: 10.1016/j.fertnstert.2016.08.045. Epub 2016 Sep 28.
10
Primary Ovarian Insufficiency.原发性卵巢功能不全
Semin Reprod Med. 2016 Jul;34(4):230-4. doi: 10.1055/s-0036-1585402. Epub 2016 Aug 11.
Zotero 插件